Extremity Reconstruction Market By Type (Upper Extremity, Lower Extremity, Partial Shoulder Replacement, Total Standard Replacement, Stemless Total Shoulder Replacement, Total Reverse Replacement, Elbow, Hand and Wrist, Hind foot Fusion, Ankle Fusion, Ankle Replacement), Biomaterials (Metallic, Polymeric, Ceramic and Natural) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

September 2016 | 127 pages | ID: E32DBA4BC2EEN
Allied Market Research

Abstracts

Extremities are external articulated organs, which execute various locomotive functions. The human body has four extremities, i.e., two upper limbs and two lower limbs. In the recent times, leading players have increased their focus on the extremity reconstruction market, as the joint reconstruction market especially hips and knee reconstruction segment has witnessed sluggish growth in the recent years. Extremity reconstruction market is a small segment of the orthopedic industry, but is the fastest growing market for reconstructive joint replacements. The world extremity reconstruction market was $1,833 million in 2015 and is expected to reach $3,041 million by 2022, growing at a CAGR of 7.5% from 2016 to 2022.
The world extremity reconstruction market is driven by increase in the number of joint disorders such as osteoarthritis and rheumatoid arthritis coupled with increase in geriatric population and rapid rise in lifestyle-related disorders, such as obesity and diabetes that lead to joint disorders. In addition, increasing awareness of patients for better treatment options and need for better quality of living are expected to propel the market. Changes in clinical practice patterns, technological advancements such as reversed shoulder instead of anatomic shoulder and ankle arthroplasty for treating ankle fusion, and development of minimally invasive techniques such as stemless shoulder implants are expected to boost the market growth. However, high cost factor and failures & complications associated with the surgery are expected to hamper the market growth.
The world extremity reconstruction market is segmented on the basis of product, biomaterial, and geography. Based on product, the market is segmented mainly into upper extremity reconstruction and lower extremity reconstruction. Upper extremity reconstruction segment is subsegmented into shoulder, elbow, and hand & wrist. Lower extremity reconstruction is subsegmented into foot & ankle. Shoulder replacement has the largest market share, owing to the largest patient population and technological advancements in shoulder implants such as reverse shoulder implants and stemless implants. Ankle replacement market is expected to grow at the fastest rate due to technological advancements in this sector and positive outcome of ankle replacement to regain movement of ankles. Based on biomaterial, the market is segmented into metallic, ceramic, polymer, and natural biomaterials. Metallic biomaterials segment has the highest share in the extremity reconstruction devices, as these are preferable biomaterials for joint replacement devices due to their strength. The geographical segmentation of the market includes North America, Europe, Asia-Pacific, and LAMEA. North America has the highest market share due to high awareness among patients, increased desire to improve quality of life, and technological advancements in extremity reconstruction devices in the region. Asia-Pacific is expected to witness maximum growth due to increasing expenditure on healthcare, improving healthcare infrastructure, and increasing awareness among patients.
Merger & acquisition is the mostly adopted strategy in the extremity reconstruction market. In October 2015, Wright Medical Group, Inc. and Tornier N.V. merged to form Wright Medical Group N.V. This helped Wright Medical Group N.V. to establish itself as a premier, high-growth extremities biologics company in the extremity reconstruction market. In the same year, Zimmer and Biomet merged to form Zimmer Biomet Holdings to enhance its product offerings in the extremity reconstruction market.
Below key market players are profiled in the report

• DePuy Synthes (a wholly owned subsidiary of Johnson & Johnson)
• Smith & Nephew plc
• Stryker Corporation
• Integra Lifesciences Holdings Corporation
• Zimmer Biomet Holdings, Inc.
• Wright Medical Group N.V.
• CONMED Corporation
• Acumed, Inc., Arthrex, Inc.
• Skeletal Dynamics LLC.

KEY MARKET BENEFITS

• The study provides an in-depth analysis of the world extremity reconstruction market along with current trends and future estimations to elucidate the imminent investment pockets.
• The report provides a quantitative analysis from 2014 to 2022 to enable stakeholders to capitalize on the prevailing market opportunities.
• Extensive analysis of products helps in understanding the types of products used across various geographies.
• Competitive intelligence highlights the business practices followed by leading players across various regions.
• Comprehensive analysis of geographical regions are provided to determine the prevailing opportunities in these geographies.
• The key players of the world extremity reconstruction market have been profiled in the report, and their strategies have been analyzed thoroughly to understand the competitive outlook of the global market
• Extensive analysis of the market is conducted by closely following key product positioning and monitoring the top contenders within the market framework.

KEY MARKET SEGMENTS

The world extremity reconstruction market is segmented based on product, applications, biomaterial and geography.
World Extremity Reconstruction Market By Product

• Upper Extremity Reconstruction
• Shoulder
• Partial Shoulder Replacement
• Total Standard Replacement
• Stemless Total Shoulder Replacement
• Total Reverse Replacement
• Elbow
• Hand & Wrist
• Lower Extremity Reconstruction
• Foot Devices
• Hind foot Fusion
• Other Fusions
• Ankle Reconstruction Devices
• Ankle Fusion
• Ankle Replacement

World Extremity Reconstruction Market By Biomaterial

• Metallic Biomaterial
• Ceramic Biomaterial
• Polymeric Biomaterial
• Natural Biomaterial

World Extremity Reconstruction Market By Geography

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Spain
• Rest of Europe
• Asia-Pacific
• Japan
• China
• India
• South Korea
• Malaysia
• Rest of Asia-Pacific
• LAMEA
• Brazil
• Israel
• South Africa
• Saudi Arabia
• Others

Contents

CHAPTER 1 INTRODUCTION

1.1 Report description
1.2 Key benefits
1.3 Research methodology
  1.3.1 Secondary research
  1.3.2 Primary research
  1.3.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO Perspective

CHAPTER 3 MARKET OVERVIEW

3.1 Market Definition & Scope
3.2 Key Findings
  3.2.1 Top Investment Pockets
  3.2.2 Top Winning Strategies
3.3 Porters Five Forces Analysis
  3.3.1 Bargaining power of suppliers
  3.3.2 Bargaining power of buyers
  3.3.3 Threat of new entrants
  3.3.4 Intensity of rivalry
  3.3.5 Threat of substitutes
3.4 Market Share Analysis, 2015
3.5 Market Dynamics
  3.5.1 Drivers
    3.5.1.1 Increasing incidences of joint disabling diseases, trauma anD sports injuries
    3.5.1.2 Technological advancements in the field of extremity implants
    3.5.1.3 Increasing awareness and patient preference to maintain an active lifestyle
    3.5.1.4 Obesity and diabetes epidemic increasing the risk of degenerative joint diseases
  3.5.2 Restraints
    3.5.2.1 High cost of surgeries
    3.5.2.2 Failure, complications, and revision of surgeries and lack of trained professionals
  3.5.3 Opportunities
    3.5.3.1 Huge market opportunities in the Asia-pacific region and developing countries
    3.5.3.2 New product introductions with innovative technologies

CHAPTER 4 WORLD EXTREMITY RECONSTRUCTION MARKET, BY PRODUCT

4.1 Overview
  4.1.1 Market size and forecast
4.2 Upper Extremity Reconstruction
  4.2.1 Key market trend
  4.2.2 Key growth factors and opportunities
  4.2.3 Market size and forecast
  4.2.4 Shoulder Replacement
    4.2.4.1 Market size and forecast
    4.2.4.2 Partial Shoulder Replacement
      4.2.4.2.1 MARKET SIZE AND FORECAST
    4.2.4.3 Total Standard Replacement
      4.2.4.3.1 MARKET SIZE AND FORECAST
    4.2.4.4 Stemless Total Shoulder Replacement
      4.2.4.4.1 MARKET SIZE AND FORECAST
    4.2.4.5 Total Reverse Replacement
      4.2.4.5.1 MARKET SIZE AND FORECAST
    4.2.4.6 Elbow replacement
      4.2.4.6.1 MARKET SIZE AND FORECAST
    4.2.4.7 Hand and wrist reconstruction
      4.2.4.7.1 MARKET SIZE AND FORECAST
4.3 Lower Extremity Reconstruction
  4.3.1 Key market trend
  4.3.2 Key growth factors and opportunities
  4.3.3 Market size and forecast
  4.3.4 Foot Devices
    4.3.4.1 Market size and forecast
    4.3.4.2 Hindfoot Fusion Devices
      4.3.4.2.1 MARKET SIZE AND FORECAST
    4.3.4.3 Other fusion devices
      4.3.4.3.1 MARKET SIZE AND FORECAST
  4.3.5 Ankle Devices
    4.3.5.1 Market size and forecast
    4.3.5.2 Ankle fusion devices
      4.3.5.2.1 MARKET SIZE AND FORECAST
    4.3.5.3 Total Ankle replacement devices
      4.3.5.3.1 MARKET SIZE AND FORECAST

CHAPTER 5 WORLD EXTREMITY RECONSTRUCTION MARKET, BY BIOMATERIAL

5.1 Overview
  5.1.1 Market size and forecast
5.2 Metallic biomaterials
  5.2.1 Market size and forecast
5.3 Ceramic biomaterials
  5.3.1 Market size and forecast
5.4 Polymeric Biomaterials
  5.4.1 Market size and forecast
5.5 Natural biomaterials
  5.5.1 Market size and forecast

CHAPTER 6 WORLD EXTREMITY RECONSTRUCTION MARKET, BY GEOGRAPHY

6.1 Overview
  6.1.1 Market size and forecast
6.2 North America
  6.2.1 Key market trends
  6.2.2 Key growth factors and opportunities
  6.2.3 Market size and forecast
  6.2.4 U.S. Market Size and Forecast
  6.2.5 Canada: Market Size and Forecast
  6.2.6 Mexico: Market Size and Forecast
6.3 Europe
  6.3.1 Key market trends
  6.3.2 Key growth factors and opportunities
  6.3.3 Market size and forecast
  6.3.4 Germany: Market Size and Forecast
  6.3.5 France: Market Size and Forecast
  6.3.6 U.K.: Market Size and Forecast
  6.3.7 Italy: Market Size and Forecast
  6.3.8 Spain: Market Size and Forecast
  6.3.9 Rest of Europe: Market Size and Forecast
6.4 Asia-Pacific
  6.4.1 Key market trends
  6.4.2 Key growth factors and opportunities
  6.4.3 Market size and forecast
  6.4.4 Japan: Market Size and Forecast
  6.4.5 China: Market Size and Forecast
  6.4.6 India: Market Size and Forecast
  6.4.7 South Korea: Market Size and Forecast
  6.4.8 Malaysia: Market Size and Forecast
  6.4.9 Rest of Asia-Pacific: Market Size and Forecast
6.5 LAMEA
  6.5.1 Key market trends
  6.5.2 Key growth factors and opportunities
  6.5.3 Market size and forecast
  6.5.4 Brazil: Market Size and Forecast
  6.5.5 Israel: Market Size and Forecast
  6.5.6 Saudi Arabia: Market Size and Forecast
  6.5.7 South Africa: Market Size and Forecast
  6.5.8 Rest of LAMEA: Market Size and Forecast

CHAPTER 7 COMPANY PROFILES

7.1 Acumed LLC
  7.1.1 Company Overview
  7.1.2 Company Snapshot
  7.1.3 Operating Business Segments
  7.1.4 Key Strategic Moves & Developments
7.2 Arthrex, INC.
  7.2.1 Company Overview
  7.2.2 Company Snapshot
  7.2.3 Operating business segments
  7.2.4 Key Strategic Moves & Developments
7.3 CONMED Corporation
  7.3.1 Company Overview
  7.3.2 Company Snapshot
  7.3.3 Operating business segments
  7.3.4 Business performance
  7.3.5 Key Strategic Moves & Developments
7.4 Integra Lifesciences Holdings Corporation
  7.4.1 Company Overview
  7.4.2 Company Snapshot
  7.4.3 Operating business segments
  7.4.4 Business performance
  7.4.5 Key Strategic Moves & Developments
7.5 Johnson & Johnson
  7.5.1 Company Overview
  7.5.2 Company Snapshot
  7.5.3 Operating business segments
  7.5.4 Business performance
  7.5.5 Key Strategic Moves & Developments
7.6 Skeletal Dynamics LLC
  7.6.1 Company Overview
  7.6.2 Company Snapshot
  7.6.3 Operating Business Segments
7.7 Smith & Nephew plc
  7.7.1 Company Overview
  7.7.2 Company Snapshot
  7.7.3 Operating business segments
  7.7.4 Business performance
  7.7.5 Key Strategic Moves & Developments
7.8 Stryker Corporation
  7.8.1 Company Overview
  7.8.2 Company Snapshot
  7.8.3 Operating business segments
  7.8.4 Business performance
  7.8.5 Key Strategic Moves & Developments
7.9 Wright Medical Group N.V.
  7.9.1 Company Overview
  7.9.2 Company Snapshot
  7.9.3 Operating business segments
  7.9.4 Business performance
  7.9.5 Key Strategic Moves & Developments
7.10 Zimmer Biomet Holdings, Inc.
  7.10.1 Company Overview
  7.10.2 Company Snapshot
  7.10.3 Operating business segments
  7.10.4 Business performance
  7.10.5 Key Strategic Moves & Developments

List Of Tables

LIST OF TABLES

TABLE 1 EXTREMITY RECONSTRUCTION MARKET, BY PRODUCT, 20142022 ($MILLION)
TABLE 2 WORLD UPPER EXTREMITY RECONSTRUCTION MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 3 SHOULDER EXTREMITY RECONSTRUCTION MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 4 SHOULDER EXTREMITY RECONSTRUCTION MARKET, BY TYPE, 20142022, (UNITS)
TABLE 5 SHOULDER EXTREMITY RECONSTRUCTION, BY TYPE, 20142022 (AVERAGE SELLING PRICE IN $, PER UNIT)
TABLE 6 LOWER EXTREMITY RECONSTRUCTION MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 7 FOOT FUSION MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 8 FOOT FUSION MARKET, BY TYPE, (UNITS) 20142022
TABLE 9 FOOT FUSION, BY TYPE, 20142022, (AVERAGE SELLING PRICE IN $, PER UNIT)
TABLE 10 ANKLE DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 11 ANKLE DEVICES MARKET, BY TYPE, 20142022, (UNITS)
TABLE 12 ANKLE DEVICES, BY TYPE, 20142022, (AVERAGE SELLING PRICE IN $, PER UNIT)
TABLE 13 WORLD EXTREMITY RECONSTRUCTION MARKET, BY MATERIAL, 20142022 ($MILLION)
TABLE 14 EXTREMITY RECONSTRUCTION FOR METALLIC BIOMATERIALS, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 15 EXTREMITY RECONSTRUCTION FOR CERAMIC BIOMATERIALS, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 16 EXTREMITY RECONSTRUCTION MARKET FOR POLYMERIC BIOMATERIALS, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 17 EXTREMITY RECONSTRUCTION FOR NATURAL BIOMATERIALS, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 18 EXTREMITY RECONSTRUCTION MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 19 NORTH AMERICA EXTREMITY RECONSTRUCTION MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 20 NORTH AMERICA UPPER EXTREMITY RECONSTRUCTION MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 21 NORTH AMERICA LOWER EXTREMITY RECONSTRUCTION MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 22 NORTH AMERICAN EXTREMITY RECONSTRUCTION MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 23 NORTH AMERICAN EXTREMITY RECONSTRUCTION MARKET, BY BIOMATERIAL, 20142022 ($MILLION)
TABLE 24 EUROPE EXTREMITY RECONSTRUCTION MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 25 EUROPE UPPER EXTREMITY RECONSTRUCTION MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 26 EUROPE LOWER EXTREMITY RECONSTRUCTION MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 27 EUROPEAN EXTREMITY RECONSTRUCTION MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 28 EUROPEAN EXTREMITY RECONSTRUCTION MARKET, BY BIOMATERIAL, 20142022 ($MILLION)
TABLE 29 ASIA-PACIFIC EXTREMITY RECONSTRUCTION MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 30 ASIA-PACIFIC UPPER EXTREMITY RECONSTRUCTION MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 31 ASIA-PACIFIC LOWER EXTREMITY RECONSTRUCTION MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 32 ASIA-PACIFIC EXTREMITY RECONSTRUCTION MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 33 ASIA-PACIFIC EXTREMITY RECONSTRUCTION MARKET, BY BIOMATERIAL, 20142022 ($MILLION)
TABLE 34 LAMEA EXTREMITY RECONSTRUCTION MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 35 LAMEA UPPER EXTREMITY RECONSTRUCTION MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 36 LAMEA UPPER EXTREMITY RECONSTRUCTION MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 37 LAMEA EXTREMITY RECONSTRUCTION MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 38 LAMEA EXTREMITY RECONSTRUCTION MARKET, BY BIOMATERIAL, 20142022 ($MILLION)
TABLE 39 ACUMED- COMPANY SNAPSHOT
TABLE 40 ACUMED- OPERATING SEGMENTS
TABLE 41 ARTHREX- COMPANY SNAPSHOT
TABLE 42 ARTHREX-OPERATING SEGMENTS
TABLE 43 CONMED CORPORATION-COMPANY SNAPSHOT
TABLE 44 CONMED CORPORATION- OPERATING SEGMENTS
TABLE 45 INTEGRA- COMPANY SNAPSHOT
TABLE 46 INTEGRA- OPERATING SEGMENTS
TABLE 47 JOHNSON & JOHNSON- COMPANY SNAPSHOT
TABLE 48 JOHNSON & JOHNSON- OPERATING SEGMENTS
TABLE 49 SKELETAL DYNAMICS - COMPANY SNAPSHOT
TABLE 50 SKELTAL DYNAMICS- OPERATING SEGMENTS
TABLE 51 SMITH & NEPHEW-COMPANY SNAPSHOT
TABLE 52 STRYKER- COMPANY SNAPSHOT
TABLE 53 STRYKER- OPERATING SEGMENTS
TABLE 54 WRIGHT-COMPANY SNAPSHOT
TABLE 55 WRIGHT- OPERATING SEGMENTS
TABLE 56 ZIMMER BIOMET- COMPANY SNAPSHOT
TABLE 57 ZIMMER BIOMET- OPERATING SEGMENTS

List Of Figures

LIST OF FIGURES

FIG. 1 TOP INVESTMENT POCKETS IN WORLD EXTREMITY RECONSTRUCTION MARKET
FIG. 2 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (20142016)
FIG. 3 TOP WINNING STRATEGIES: NATURE AND TYPE
FIG. 4 PORTERS FIVE FORCES ANALYSIS
FIG. 5 MARKET SHARE ANALYSIS, 2015
FIG. 6 TOP IMPACTING FACTORS: WORLD EXTREMITY RECONSTRUCTION MARKET, 20142022
FIG. 7 WORLD EXTREMITY RECONSTRUCTION MARKET, BY REGION
FIG. 8 U.S. EXTREMITY RECONSTRUCTION MARKET, (20142022) ($MILLION)
FIG. 9 CANADA EXTREMITY RECONSTRUCTION MARKET, (20142022) ($MILLION)
FIG. 10 MEXICO EXTREMITY RECONSTRUCTION MARKET, (20142022) ($MILLION)
FIG. 11 GERMANY EXTREMITY RECONSTRUCTION MARKET, (20142022) ($MILLION)
FIG. 12 FRANCE EXTREMITY RECONSTRUCTION MARKET, (20142022) ($MILLION)
FIG. 13 U.K. EXTREMITY RECONSTRUCTION MARKET, (20142022) ($MILLION)
FIG. 14 ITALY EXTREMITY RECONSTRUCTION MARKET, (20142022) ($MILLION)
FIG. 15 SPAIN EXTREMITY RECONSTRUCTION MARKET, (20142022) ($MILLION)
FIG. 16 REST OF EUROPE EXTREMITY RECONSTRUCTION MARKET, (20142022) ($MILLION)
FIG. 17 JAPAN EXTREMITY RECONSTRUCTION MARKET, (20142022) ($MILLION)
FIG. 18 CHINA EXTREMITY RECONSTRUCTION MARKET, (20142022) ($MILLION)
FIG. 19 INDIA EXTREMITY RECONSTRUCTION MARKET, (20142022) ($MILLION)
FIG. 20 SOUTH KOREA EXTREMITY RECONSTRUCTION MARKET, (20142022) ($MILLION)
FIG. 21 MALAYSIA EXTREMITY RECONSTRUCTION MARKET, (20142022) ($MILLION)
FIG. 22 REST OF ASIA-PACIFIC EXTREMITY RECONSTRUCTION MARKET, (20142022) ($MILLION)
FIG. 23 BRAZIL EXTREMITY RECONSTRUCTION MARKET, (20142022) ($MILLION)
FIG. 24 ISRAEL EXTREMITY RECONSTRUCTION MARKET, (20142022) ($MILLION)
FIG. 25 SAUDI ARABIA EXTREMITY RECONSTRUCTION MARKET, (20142022) ($MILLION)
FIG. 26 SOUTH AFRICA EXTREMITY RECONSTRUCTION MARKET, (20142022) ($MILLION)
FIG. 27 REST OF LAMEA EXTREMITY RECONSTRUCTION MARKET, (20142022) ($MILLION)
FIG. 28 CONMED CORPORATION- REVENUE, 20132015, ($MILLION)
FIG. 29 CONMED CORPORATION-REVENUE, BY SEGMENTS, 2015 (%)
FIG. 30 CONMED CORPORATION- REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 31 INTEGRA- REVENUE, 20132015, ($MILLION)
FIG. 32 INTEGRA- REVENUE, BY SEGMENT, 2015 (%)
FIG. 33 INTEGRA- REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 34 INTEGRA- STRATEGY SHARE, 2015 (%)
FIG. 35 JOHNSON & JOHNSON- REVENUE, 20132015, ($MILLION)
FIG. 36 JOHNSON & JOHNSON-REVENUE, BY BUSINESS SEGMENT, 2015 (%)
FIG. 37 JOHNSON & JOHNSON- REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 38 JOHNSON & JOHNSON- STRATEGY SHARE, 2015 (%)
FIG. 39 SMITH & NEPHEW- REVENUE, 20132015, ($MILLION)
FIG. 40 SMITH & NEPHEW-REVENUE, BY SEGMENT, 2015 (%)
FIG. 41 SMITH & NEPHEW- REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 42 SMITH & NEPHEW- STRATEGY SHARE, 2015 (%)
FIG. 43 STRYKER- REVENUE, 20132015, ($MILLION)
FIG. 44 STRYKER- REVENUE, BY SEGMENT, 2015 (%)
FIG. 45 STRYKER- REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 46 WRIGHT- REVENUE, 20132015, ($MILLION)
FIG. 47 WRIGHT- REVENUE, BY SEGMENT, 2015 (%)
FIG. 48 WRIGHT- REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 49 WRIGHT- STRATEGY SHARE, 2015 (%)
FIG. 50 ZIMMER BIOMET- REVENUE, 2013-2015, ($MILLION)
FIG. 51 ZIMMER BIOMET- REVENUE, BY PRODUCT TYPE CATEGORY, 2015 (%)
FIG. 52 ZIMMER BIOMET- REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 53 ZIMMER BIOMET- STRATEGY SHARE, 2015 (%)